Skip to main content
Loading

A collaborative approach to improving cardiovascular disease outcomes

13 Jun 2024
Improving outcomes theatre
Improving outcomes , Learning theatre , Supporter session

This session shares insights from a disease prevalence quality improvement programme delivered at primary care networks across Coventry and Warwickshire ICB. The session will also focus on a collaborative lipid management programme supported by industry, which proactively identifies and reviews patients requiring lipid optimisation for secondary prevention of atherosclerotic cardiovascular disease to prevent further cardiovascular events.

This session is supported by IQVIA

Speakers
Jim McArdle, Strategy Lead, Patient Services - IQVIA UKI
Danny Moore, Strategic Account Director - Novartis
Laura Siepker, Associate Director, Service Development - IQVIA
Dr Matt Kearney, Senior Advisor to UCLPartners, GP and Founder of CVDACTION and CVDprevent - UCLPartners
Ryan Smith, Strategic Business Manager, Kenilworth & Warwick PCN and Chair, IT Board, Coventry & Warwickshire ICS - Coventry & Warwickshire ICB

IQVIA